Use of atropine in patients with submaximal heart rate during exercise myocardial perfusion SPECT

Journal of Nuclear Cardiology

Volumn 10, Issue 1, 2003, Pages 51-55

  De Lorenzo, Andrea ^a   Foerster, James ^b   Sciammarella, Maria G ^a   Suey, Cathy ^b   Hayes, Sean W ^a   Friedman, John D ^a   Berman, Daniel S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b NONE

Author keywords

Atropine; Coronary artery disease; Maximal predicted heart rate; Myocardial perfusion single photon emission computed tomography

Indexed keywords

AMIODARONE; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOSE RESPONSE; DRUG USE; EXERCISE TEST; FATIGUE; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RATE; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; IMAGE ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPRAVENTRICULAR PREMATURE BEAT; TREADMILL EXERCISE; XEROSTOMIA;

EID: 0037226130     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2003.23     Document Type: Article

References (21)

1. Iskandrian AS, Heo J, Kong B, Lyons E. Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 1989;14:1477-86.
2. Verzijlbergen JF, Vermeersch PHMJ, Laarman G, Ascoop CAPL. Inadequate exercise leads to suboptimal imaging. Thallium-201 myocardial perfusion imaging after dipyridamole combined with low-level exercise unmasks ischemia in symptomatic patients with non-diagnostic thallium-201 scans who exercise submaximally. J Nucl Med 1991;32:2071-8.
3. Heller GV, Ahmed I, Tilkemeier PL, Barbour MM, Garber CE. Influence of exercise intensity on the presence, distribution and size of thallium-201 defects. Am Heart J 1992;123:909-16.
4. Iskandrian AS, Verani MS, Heo JH. Pharmacologic stress testing: mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol 1994;1:94-111.
5. McNeill AJ, Fioretti PM, el-Said SM, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. Am J Cardiol 1992;70:41-6.
6. Secknus MA, Marwick TH. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 1997;29:1234-40.
7. Geleijnse ML, Elhendy A, van Domburg RT, et al. Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain: echocardiography, perfusion scintigraphy, or both? Circulation 1997;96:137-47.
8. Elhendy A, Valkema R, van Domburg RT, et al. Safety of dobutamine-atropine stress myocardial perfusion scintigraphy. J Nucl Med 1998;39:1662-6.
9. Elhendy A, van Domburg RT, Bax JJ, et al. The functional significance of chronotropic incompetence during dobutamine stress test. Heart 1999;81:398-403.
10. Geleijnse ML, Elhendy A, Fioretti PM, Roelandt JRTC. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 2000;36:2017-27.
11. Elhendy A, van Domburg RT, Bax JJ, et al. Safety, hemodynamic profile, and feasibility of dobutamine stress technetium myocardial perfusion single-photon emission CT imaging for evaluation of coronary artery disease in the elderly. Chest 2000;117:649-56.
12. Berman DS, Kiat H, Friedman JD, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
13. Diamond GA, Staniloff HM, Forrester JS, Pollock BH, Swan HJC. Computed assisted diagnosis in the noninvasive evaluation of patients with suspected coronary artery disease. J Am Coll Cardiol 1983;1:444-55.
14. McLaughlin PR, Martin RP, Doherty P, et al. Reproducibility of thallium-201 myocardial imaging. Circulation 1977;55:497-503.
15. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol 1986;7:464-71.
16. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease. Incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
17. David D, Lang RM, Borow KM. Clinical utility of exercise, pacing, and pharmacologic stress testing for the noninvasive determination of myocardial contractility and reserve. Am Heart J 1988;116:235-47.
18. Rallidis L, Cokkinos P, Tousoulis D, Nihoyannopoulos P. Comparison of dobutamine and treadmill exercise echocardiography in inducing ischemia in patients with coronary artery disease. J Am Coll Cardiol 1997;30:1660-8.
19. Mairesse GH, Vanoverschelde JJ, Robert A, et al. Pathophysiologic mechanisms underlying dobutamine- and exercise-induced wall motion abnormalities. Am Heart J 1998;136:63-70.
20. Atar S, Nagai T, Cercek B, et al. Pacing stress echocardiography: an alternative to pharmacologic stress testing. J Am Coll Cardiol 2000;36:1935-41.
21. Katzung BG. Basic and clinical pharmacology. New York: Lange Medical, McGraw-Hill; 2001 p. 115.